At its launch in June 2021, Organon launched a commitment: to listen to women worldwide, to understand ‘her’ health needs and help identify solutions that are urgently needed. “Because there is a need to address diseases and conditions that only or disproportionately impact women”, says Petra Willems, Managing Director of Organon Benelux. “Our impact will go beyond medicine, contraception and fertility treatments. Because we know that we can do so much more for women and their health. That is why we are proud that we have been able to realize a strategic partnership in the Benelux so quickly.”

A lot of experience
Establishing close collaboration with external partners is a key tenet in the Organon strategy, whether it is to develop new therapies or to give more women access to existing products. The partnership with the Dutch company Titus Health Care is an excellent example of this.
Freek Hendriksen, who is responsible for Alliance & Business Development within the management team of Organon Benelux, says: “The Titus Health Care team is very experienced in training healthcare professionals and has a large network and a strong reputation in healthcare. Its entrepreneurial culture and mindset are also an excellent fit with Organon’s.”

Join forces
Together, the companies will work on improving awareness of and access to long-acting contraceptive methods. “Every woman is unique and that requires tailormade contraceptive advice. That is why Titus Health Care and Organon are joining forces. We share the ambition to contribute to the education of healthcare providers so that they can give women appropriate advice about contraception,” says Judith Wiegant, Managing Director of Titus Health Care.
“We are joining forces with a broad portfolio of hormonal and non-hormonal contraception”, adds the company’s founder and co-director Joep de Mönnink. “To offer women optimal freedom of choice.”